StockData
ELI LILLY & Co logo

ELI LILLY & Co (LLY) stock

LLYNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 19/3021% above fair value
$1351.12−31.63 (-2.29%)

Close on Nov 19, 2026Market cap $1.27TP/E 43.9Yield 0.46%

Eli Lilly free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

Quarterly free cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2022Sep 30, 2022$1.60B+14.7%
Q2 FY2022Jun 30, 2022$812.30M-41.9%
Q1 FY2022Mar 31, 2022$2.16B+52.6%
Q3 FY2021Sep 30, 2021$1.29B-41.5%
Q2 FY2021Jun 30, 2021$1.39B+1023.4%
Q1 FY2021Mar 31, 2021$1.40B+12.1%
Q3 FY2020Sep 30, 2020$1.41B+74.2%
Q2 FY2020Jun 30, 2020$2.21B+1957.2%
Q1 FY2020Mar 31, 2020$124.10M–
Q3 FY2019Sep 30, 2019$1.25B–
Q2 FY2019Jun 30, 2019$811.20M–
Q1 FY2019Mar 31, 2019$107.60M–

More Eli Lilly figures

See a number that looks wrong?